(PharmaNewsWire.Com, January 27, 2017 ) Global Head and Neck Cancer Diagnostics Market is projected to reach 11,508 million by 2021, at a CAGR of 11.52% from 2016 to 2021.For full report refer to http://www.marketdataforecast.com/market-reports/head-and-neck-cancer-diagnostics-market-49/Head and...
(PharmaNewsWire.Com, January 27, 2017 ) DelveInsight's, “Cryptococcosis-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Cryptococcosis. The DelveInsight'sReport covers the product profiles in various stages of development...
(PharmaNewsWire.Com, January 27, 2017 ) DelveInsight's Report, "Atelectasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective...
(PharmaNewsWire.Com, January 28, 2017 ) Published On : Sep 22,2016The global special purpose needles market is projected to be valued at US$ 17,261.5 million by the end of 2026, registering a CAGR of 7.4% during the forecast period (2016–2026). In a new report titled “Special Purpose Needles Market:...
(PharmaNewsWire.Com, January 27, 2017 ) DelveInsight's, “Chronic Bronchitis-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Chronic Bronchitis. The DelveInsight'sReport covers the product profiles in various stages of...
(PharmaNewsWire.Com, January 28, 2017 ) Around 30% of total death worldwide is caused by cardiovascular diseases, of which major part is accounted by heart diseases. The risk factors of heart disease includes elevated cholesterol levels, diabetes mellitus, cigarette smoking, obesity and hypertension....
(PharmaNewsWire.Com, January 28, 2017 ) Obese people are increasing globally, which is leading to many diseases such as heart diseases, hypertension, cancer, high blood pressure and diabetes. Treatment of such diseases is quite expensive and government has to bear the costs to improve the healthcare...
(PharmaNewsWire.Com, January 28, 2017 ) Skin is the largest organ in human body which is highly dynamic in nature. It is composed of two layers, the outer layer called epidermis and the inner layer called dermis. Its network of nerves, blood vessels and cells thus acting as a protective armor. It...
(PharmaNewsWire.Com, January 27, 2017 ) Publisher's, "Neutrophil Elastase Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Neutrophil Elastase Inhibitors. The Publisher's Report covers the product profiles in...
(PharmaNewsWire.Com, January 27, 2017 ) DelveInsight's, “Bronchiectasis-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Bronchiectasis. The DelveInsight'sReport covers the product profiles in various stages of development...
(PharmaNewsWire.Com, January 27, 2017 ) DelveInsight's Report, "Nasopharyngitis (Common Cold)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross...
(PharmaNewsWire.Com, January 27, 2017 ) Publisher's, "Lysine Specific Demethylase 1 (LSD-1) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Lysine Specific Demethylase 1 (LSD-1) Inhibitors. The Publisher's Report...
(PharmaNewsWire.Com, January 27, 2017 ) DelveInsight's Report, "Haemophilus Influenzae Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross...
(PharmaNewsWire.Com, January 27, 2017 ) Publisher's, "Interleukin-13 (IL-13) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Interleukin-13 (IL-13) Inhibitors. The Publisher's Report covers the product profiles...
(PharmaNewsWire.Com, January 27, 2017 ) DelveInsight's Report, "Bipolar Disorder (Manic Depression)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross...
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
